Arginine methylation regulates c-Myc-dependent transcription by altering promoter recruitment of the acetyltransferase p300

  1. Steven A Weinman*
  1. University of Kansas Medical Center, United States
  1. * Corresponding author; email: sweinman{at}kumc.edu
  1. Author contributions: I.T. and S.A.W. designed the research, analyzed the results, and wrote the manuscript; I.T and J.Z. performed the experiments; IT produced the figures, S.K. B.B., B.R., collected human specimens. All authors analyzed the results and approved the final version of the manuscript

Abstract

Protein arginine methyltransferase 1 (PRMT1) is an essential gene controlling about 85% of total cellular arginine methylation in proteins. We have previously shown that PRMT1 is an important regulator of innate immune responses and that it is required for M2 macrophage differentiation. c-Myc is a transcription factor that is critical in regulating cell proliferation and also regulates the M2 transcriptional program in macrophages. Here, we sought to determine whether c-Myc in myeloid cells is regulated by PRMT1-dependent arginine methylation. We found that PRMT1 activity was necessary for c-Myc binding to the acetyltransferase p300. PRMT1 inhibition decreased p300 recruitment to c-Myc target promoters and increased histone deacetylase 1 (HDAC1) recruitment, thereby decreasing transcription at these sites. Moreover, PRMT1 inhibition blocked c-Myc-mediated induction of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARγ) and mannose receptor C-type 1 (CD206), suggesting that PRMT1 is necessary for c-Myc function in M2 macrophage differentiation. Of note, in primary human blood monocytes, p300-c-Myc binding was strongly correlated with PRMT1 expression, and in liver sections, PRMT1, c-Myc, and M2 macrophage levels were strongly correlated with each other. Both PRMT1 levels and M2 macrophage numbers were significantly lower in livers from individuals with a history of spontaneous bacterial peritonitis, known to have defective cellular immunity. In conclusion, our findings demonstrate that PRMT1 is an important regulator of c-Myc function in myeloid cells. PRMT1 loss in individuals with cirrhosis might contribute to their immune defects

  • Received May 19, 2017.
  • Accepted June 26, 2017.

Submit your work to JBC.

You'll be in good company.